Acquisition expands AbbVie's psychiatry pipeline with the addition of a next-generation psychedelic compound currently in Phase 2 development for the treatment of major depressive disorder
Through this acquisition Merck has added Ohtuvayre (ensifentrine) to its growing cardio-pulmonary pipeline and portfolio
Quest will now offer dialysis-related clinical testing services to independent dialysis clinics
The transaction enhances Roquette’s ability to deliver high-value drug delivery solutions to pharmaceutical customers worldwide
The transaction structured as share swap, is valued at ~Rs. 849 crore, with no cash outflow
Strengthening capabilities in Peptide Therapeutics and CDMO services
Positions Curium as leading manufacturer of Lu-177 isotope
The new site will increase Syngene's total single-use bioreactor capacity to 50,000L
Subscribe To Our Newsletter & Stay Updated
